One of those conditions is sepsis. More patients die from sepsis than AIDS, prostate cancer and breast cancer combined. Early diagnosis is essential to fight conditions like sepsis, but biochemical limitations mean that patients often get caught too late.
Dascena develops algorithms as a new category of diagnostics to catch patients earlier when they can be effectively treated.
Our founder, Ritankar Das, began developing algorithms to help diagnose complex clinical conditions while a PhD student at the University of Cambridge. His mentor, Dr. P. Roy Vagelos, encouraged him to start a company in order to bring these life-saving algorithms to patients, and became our first investor. Subsequently, the company received four grants from the National Institutes of Health (NIH) to develop the technology and perform clinical trials. Today, our algorithms are used by over 50,000 clinicians and helps save thousands of lives.